Table 1.

Adolescents with SCD admitted to US children’s hospitals, PHIS, 2010-2021

Characteristic  
Unique patients 7202 
Unique admissions 34 094 
Age at first admission median (range) 15.6 y (13.0-21.9) 
Male sex, n (%) 3549 (49.3) 
Race, n (%)  
Black 6507 (90.3) 
White 184 (2.6) 
Other/Unknown 511 (7.1) 
Ethnicity, n (%)  
Non-Hispanic/Latino 6418 (89.1) 
Hispanic/Latino 328 (4.6) 
Unknown 456 (6.3) 
Insurance type, n (%)  
Public 4829 (67.1) 
Private 2061 (28.6) 
Other (self-pay, charity) 255 (3.5) 
Unknown 56 (0.8) 
Region, n (%)  
Midwest 1604 (22.3) 
Northeast 1138 (15.8) 
South 3723 (51.7) 
West 737 (10.2) 
Sickle Cell Genotype , n (%)  
SS 4951 (68.7) 
SC 1068 (14.8) 
Sβ thalassemia 663 (9.2) 
Nonspecific/other  520 (7.2) 
Characteristic  
Unique patients 7202 
Unique admissions 34 094 
Age at first admission median (range) 15.6 y (13.0-21.9) 
Male sex, n (%) 3549 (49.3) 
Race, n (%)  
Black 6507 (90.3) 
White 184 (2.6) 
Other/Unknown 511 (7.1) 
Ethnicity, n (%)  
Non-Hispanic/Latino 6418 (89.1) 
Hispanic/Latino 328 (4.6) 
Unknown 456 (6.3) 
Insurance type, n (%)  
Public 4829 (67.1) 
Private 2061 (28.6) 
Other (self-pay, charity) 255 (3.5) 
Unknown 56 (0.8) 
Region, n (%)  
Midwest 1604 (22.3) 
Northeast 1138 (15.8) 
South 3723 (51.7) 
West 737 (10.2) 
Sickle Cell Genotype , n (%)  
SS 4951 (68.7) 
SC 1068 (14.8) 
Sβ thalassemia 663 (9.2) 
Nonspecific/other  520 (7.2) 

This table excludes 427 patients who were documented as having VTE.

Determined by ICD coding. For patients who had multiple genotypes coded throughout the study period, the genotype that was used most frequently was chosen.

Includes nonspecific and not elsewhere classifiable SCD diagnosis codes as well as instances of a tie for the most frequently used genotype and the method described in the previous footnote could not be applied.

or Create an Account

Close Modal
Close Modal